Researchers Engineer Lysins to Target Bacteria With Surgical Precision

  05 December 2020

Researchers have devised a method to produce customizable engineered lysins capable of selectively killing bacteria without harming surrounding ones, according to a press release shared with Interesting Engineering via email.

This could be a revolutionary medical development of an exciting possible alternative to antibiotics in treating drug-resistant bacteria and bacterial infections, without unwittingly strengthening bacterial resistance and putting lives at risk.

Further reading: Interesting Engineering
Author(s): Brad Bergan
Smart Innovations  


Unrestricted financial support kindly provided by

Antimicrobial Resistance Fighter Coalition

Technology Database

Display your AMR Technology, Product and Service


Suppliers and Users of Technologies, Products and Services benefit from CAPI.
CAPI (Continuous AMR Partnering Initiative) unites Suppliers and Users worldwide with the aim to add to the curbing of AMR.


Read more and make your own Technology Page >>
What is going on with AMR?
Stay tuned with remarkable global AMR news and developments!